Printed on: Sat Jul 31 2021, 06:11:32 PM Official Status: Currently Official on 31-Jul-2021 DocId: 1_GUID-82FA76FD-9531-4C09-A5A6-DA5C9F9C521F_4_en-US

(EST)
Printed by: Le Tran Official Date: Official as of 01-May-2020 Document Type: USP @2021 USPC
1

Acceptance criteria: 90.0%–110.0%

Pseudoephedrine Hydrochloride
Extended-Release Tablets PERFORMANCE TESTS
Change to read:
DEFINITION
Pseudoephedrine Hydrochloride Extended-Release Tablets • DISSOLUTION á711ñ
contain NLT 90.0% and NMT 110.0% of the labeled amount For Tablets labeled for dosing every 12 h
of pseudoephedrine hydrochloride (C10H15NO · HCl). Test 1
Medium: Water; 900 mL
IDENTIFICATION Apparatus 2: 50 rpm
Change to read: Times: 1, 3, and 6 h
Mobile phase and System suitability: Proceed as
• A. ▲SPECTROSCOPIC IDENTIFICATION TESTS á197ñ, Infrared directed in the Assay.
Spectroscopy: 197K▲ (CN 1-May-2020) Standard solution: 0.13 mg/mL of USP
Sample: Triturate a number of Tablets, nominally equivalent Pseudoephedrine Hydrochloride RS in water
to 180 mg of pseudoephedrine hydrochloride. Filter with Sample solution: Filter a portion of the solution
about 10 mL of chloroform collected using vacuum under test.
filtration. Maintain the vacuum until no further filtrate can Chromatographic system
be collected, and evaporate the chloroform on a steam (See Chromatography á621ñ, System Suitability.)
bath, taking care to avoid overheating. Recrystallize the Mode: LC
residue from a small amount of dehydrated alcohol. Detector: UV 254 nm
Acceptance criteria: Meet the requirements Column: 4.6-mm × 15-cm; packing L3

al
• B. The retention time of the major peak of the Sample Flow rate: 0.7 mL/min
solution corresponds to that of the Standard solution, as Injection volume: 50 µL
obtained in the Assay. Analysis
Samples: Standard solution and Sample solution
ASSAY Calculate the percentage of the labeled amount of
• PROCEDURE pseudoephedrine hydrochloride (C10H15NO · HCl)
Mobile phase: Alcohol and ammonium acetate solution
(1 in 250) (850:150). Filter, and degas
Standard solution: 1.2 mg/mL of USP Pseudoephedrine
ci dissolved.
Tolerances: See Table 1.
Hydrochloride RS in alcohol Table 1
Sample stock solution: Transfer NLT 20 Tablets to a suitable
ffi
container, add 500 mL of alcohol, and homogenize until Amount
Time Dissolved
the Tablets are dispersed. Quantitatively transfer the (h) (%)
contents of the container to a 1000-mL volumetric flask,
dilute with alcohol to volume, mix, and allow to stand for 1 25–45
the solids to settle. 3 50–75
Sample solution: Transfer 25.0 mL of the supernatant
O

from the Sample stock solution into a 50-mL volumetric flask, 6 NLT 75
dilute with alcohol to volume, and mix. Pass a portion of
this solution through a filter of 0.45-µm pore size. The percentages of the labeled amount of
Chromatographic system pseudoephedrine hydrochloride (C10H15NO · HCl)
(See Chromatography á621ñ, System Suitability.) dissolved at the times specified conform to Dissolution
Mode: LC á711ñ, Acceptance Table 2.
Detector: UV 254 nm Test 3: If the product complies with this test, the labeling
Column: 4.6-mm × 15-cm; packing L3 indicates that it meets USP Dissolution Test 3.
Flow rate: 0.7 mL/min Medium: Water; 900 mL
Injection volume: 10 µL Apparatus 2: 50 rpm
System suitability Times: 1, 3, and 6 h
Sample: Standard solution Standard solution: A known concentration of USP
Suitability requirements Pseudoephedrine Hydrochloride RS in Medium.
Tailing factor: NMT 2.5 Sample solution: Pass portions of the solution under test
Relative standard deviation: NMT 2.0% through a filter of 0.45-µm pore size, and suitably
Analysis dilute with Medium.
Samples: Standard solution and Sample solution Analysis: Calculate the percentage of the labeled amount
Calculate the percentage of the labeled amount of of pseudoephedrine hydrochloride (C10H15NO · HCl)
pseudoephedrine hydrochloride (C10H15NO · HCl) in the dissolved by comparing the maximum absorbance of
portion of Tablets taken: Sample solution with that of Standard solution at about
214 nm.
Result = (rU/rS) × (CS/CU) × 100 Tolerances: See Table 2.
rU = peak response from the Sample solution Table 2
rS = peak response from the Standard solution Amount
CS = concentration of USP Pseudoephedrine Time Dissolved
Hydrochloride RS in the Standard solution (h) (%)
(mg/mL) 1 25–45
CU = nominal concentration of pseudoephedrine
hydrochloride in the Sample solution (mg/mL) 3 60–80

https://online.uspnf.com/uspnf/document/1_GUID-82FA76FD-9531-4C09-A5A6-DA5C9F9C521F_4_en-US 1/3
Printed on: Sat Jul 31 2021, 06:11:32 PM Official Status: Currently Official on 31-Jul-2021 DocId: 1_GUID-82FA76FD-9531-4C09-A5A6-DA5C9F9C521F_4_en-US
(EST)
Printed by: Le Tran Official Date: Official as of 01-May-2020 Document Type: USP @2021 USPC
2

Table 2 (continued) V = volume of the Medium, 900 mL

Amount L = label claim (mg/Tablet)
Time Dissolved VS = volume of the Sample solution withdrawn at each
(h) (%) time point (mL)
6 NLT 80
Tolerances: See Table 3.
The percentages of the labeled amount of Table 3
pseudoephedrine hydrochloride (C10H15NO · HCl)
Time Amount
dissolved at the times specified conform to Dissolution Point Time Dissolved
á711ñ, Acceptance Table 2. (i) (h) (%)
▲
Test 4: If the product complies with this test, the labeling
1 1 27–47
indicates that it meets USP Dissolution Test 4.
Medium, Apparatus, and Times: Proceed as directed in 2 3 53–73
Test 1. 3 6 NLT 80
Solution A: Acetonitrile and water (45:55)
Mobile phase: 2.5 g/L of docusate sodium in Solution A.
Add 1.0 mL of phosphoric acid. Adjust with ammonia The percentages of the labeled amount of
water, 25% to a pH of 3.2. pseudoephedrine hydrochloride (C10H15NO · HCl)
Standard solution: (L/900) mg/mL of USP dissolved at the times specified conform to Dissolution
Pseudoephedrine Hydrochloride RS in Medium, where L á711ñ, Acceptance Table 2.▲ (RB 1-Mar-2019)
is the label claim in mg/Tablet. For Tablets labeled for dosing every 24 h
Sample solution: Withdraw a portion of the solution Test 2: If the product complies with this test, the labeling

al
under test from each vessel at the specified time point indicates that it meets USP Dissolution Test 2.
and pass through a suitable filter of 0.45-µm pore size. Medium: 0.9% sodium chloride in water; 50 mL
Replace the portion of solution withdrawn with an equal Apparatus 7 (see Drug Release á724ñ): 30 cycles/min; 2–
volume of Medium previously equilibrated to 37.0° 3 cm amplitude. To prepare the sample, see Figure 1.
± 0.5°.
ci Times: 2, 8, 14, and 24 h
Chromatographic system Solution A: Transfer 200 mL of water to a 1000-mL
(See Chromatography á621ñ, System Suitability.) volumetric flask. Add 3.4 mL of phosphoric acid and
Mode: LC 5 mL of triethylamine. Add water to almost 900 mL.
Detector: UV 215 nm Adjust with 1 N sodium hydroxide to a pH of about 6.8,
Column: 4.6-mm × 15-cm; 5-μm packing L1 dilute with water to volume, and mix.
ffi
Column temperature: 40° Mobile phase: Methanol and Solution A (100:900)
Flow rate: 1.5 mL/min System suitability solution: 0.4 mg/mL of USP
Injection volume: 10 µL Pseudoephedrine Hydrochloride RS in water
Run time: NLT 1.5 times the retention time of Sample solution: Solution under test
pseudoephedrine Standard solution: Known concentrations of USP
System suitability Pseudoephedrine Hydrochloride RS in water, in a range
O

Sample: Standard solution around the expected concentration of the Sample

Suitability requirements solution at each time interval.
Tailing factor: NMT 2.0 Chromatographic system
Relative standard deviation: NMT 2.0% (See Chromatography á621ñ, System Suitability.)
Analysis Mode: LC
Samples: Standard solution and Sample solution Detector: UV 254 nm
Calculate the concentration (Ci) of pseudoephedrine Column: 4.6-mm × 5-cm; packing L1
hydrochloride (C10H15NO · HCl) in the sample Flow rate: 1.5 mL/min
withdrawn from the vessel at each time point i: Injection volume: 10 µL
System suitability
Result = (rU/rS) × CS Sample: System suitability solution
Suitability requirements
rU = peak response of pseudoephedrine from the Tailing factor: NMT 2
Sample solution Relative standard deviation: NMT 2.0%
rS = peak response of pseudoephedrine from the Analysis
Standard solution Samples: Sample solution and Standard solution
CS = concentration of USP Pseudoephedrine Measure the major peak responses of the Standard
Hydrochloride RS in the Standard solution solution and Sample solution. Construct a calibration
curve by plotting the peak response versus
Calculate the percentages of the labeled amount of concentrations of the Standard solution. Determine the
pseudoephedrine hydrochloride (C10H15NO · HCl) amount of pseudoephedrine hydrochloride (C10H15NO
dissolved at each time point i: · HCl) dissolved at each time interval from a linear
regression analysis of the calibration curve.
Result1 = C1 × V × (1/L) × 100 Tolerances: See Table ▲4▲ (RB 1-Mar-2019).
Result2 = [(C2 × V) + (C1 × VS)] × (1/L) × 100
Result3 = {(C3 × V) + [(C2 + C1) × VS]} × (1/L) × 100 Table ▲4▲ (RB 1-Mar-2019)
Amount
Ci = concentration of pseudoephedrine hydrochloride Time Dissolved
in the portion of sample withdrawn at time point (h) (%)
i (mg/mL) 2 20–35

https://online.uspnf.com/uspnf/document/1_GUID-82FA76FD-9531-4C09-A5A6-DA5C9F9C521F_4_en-US 2/3
Printed on: Sat Jul 31 2021, 06:11:32 PM Official Status: Currently Official on 31-Jul-2021 DocId: 1_GUID-82FA76FD-9531-4C09-A5A6-DA5C9F9C521F_4_en-US
(EST)
Printed by: Le Tran Official Date: Official as of 01-May-2020 Document Type: USP @2021 USPC
3

al
Figure 1. Steps to prepare the sample. (1) Place 1 Tablet on a 5-cm × 5-cm nylon netting. (2) Fold the netting over the Tablet.
ci
Continue folding until the Tablet is enclosed in the netting. (3) Fold the netting so that the two open ends meet. The Tablet
should be enveloped in the center of the netting. (4) Insert a rod (see Drug Release á724ñ, ▲Figure 5c)▲ (ERR 1-May-2019) through
the netting to secure the Tablet. (5) Secure the netting with HPLC plastic ferrules or other appropriate device. Trim the excess
netting. Attach each sample holder to the vertically reciprocating sample holder.
ffi
Table ▲4▲ (RB 1-Mar-2019) (continued) dissolved at the times specified conform to Dissolution
Amount á711ñ, Acceptance Table 2.
Time Dissolved • UNIFORMITY OF DOSAGE UNITS á905ñ: Meet the
(h) (%) requirements
8 40–65 ADDITIONAL REQUIREMENTS
O

14 60–90 • PACKAGING AND STORAGE: Preserve in tight containers.

• LABELING: When more than one Dissolution test is given, the
24 NLT 85 labeling states the Dissolution test used only if Test 1 is
not used.
The percentages of the labeled amount of • USP REFERENCE STANDARDS á11ñ
pseudoephedrine hydrochloride (C10H15NO · HCl) USP Pseudoephedrine Hydrochloride RS

https://online.uspnf.com/uspnf/document/1_GUID-82FA76FD-9531-4C09-A5A6-DA5C9F9C521F_4_en-US 3/3